High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696 (Q73567640)
scientific article published on 01 March 2001
Language:
(P31) (Q13442814)
(P304) 1430-1436
(P407) (Q1860)
(P433) 5
(P478) 19
(P577) Thursday, March 1, 2001
(P921) (Q6934595)
(Q42824440)
(P1433) (Q400292)
(P1476) "High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696" (language: en)
(P2093) J M Kirkwood
J Ibrahim
D H Lawson
M B Atkins
S S Agarwala
K Collins
R Mascari
D M Morrissey
P B Chapman
other details
description scientific article published on 01 March 2001

External Links